US FDA gives device lablers heads up on UDI database requirements
This article was originally published in Clinica
Executive Summary
The US FDA has finalized the first phase of guidelines on how medical device labelers should go about submitting unique device identification (UDI) data to the agency's database in accordance with regulatory requirements that kick in on 24 September.